Achillion Pharma Shares Up 7% Wed., At Highest Level Since Major Earnings-Related Sell Off On Sept. 8; Stock Up 19% Since Sept. 14 Lows; Not Seeing Any News To Justify Price Action Wed., But Price Notably Held Above $4 Support Level